PubMed Health⌕ Search

Biomedical subjects

M Suehiro

Publications and source records attributed to M Suehiro.

At least 55 records · Page 3Linked to original sources

[Effects of an increase or decrease in the middle ear pressure on tympanic membrane vibrations (experimental study by holographic interferometry)].

The effects of positive and negative pressure in the middle ear on tympanic membrane (TM) vibrations were studied in twenty canine temporal bones by holographic interferometry. The displacement of the TM was measured by moiré topography. 1) When pressure was applied to the tympanic cavity, the curvature of the TM became small under negative pressure and large under positive pressure, with the displacement being greater under positive pressure. 2) Without pressure load, the vibration pattern below 2 kHz was simple and there were peak displacement regions in the posterior and anterior parts of the membrane and the peaks occurred approximately halfway along the manubrium. The TM vibrations showed sectional patterns, above 3 kHz in the posterior and above 4 kHz in the anterior. The amplitude of the anterior peak was larger than that of the mallear tip, but smaller than that of the posterior. 3) At frequencies below 2 kHz, the vibration pattern was not affected by negative pressure load. At frequencies of 3 kHz or higher, the sectional patterns changed into the simpler patterns and the sectional vibrations diminished as the pressure increased. 4) Below 2 kHz, the TM amplitude decreased with increasing negative pressure. Above 3 kH, the amplitude showed an initial increase but decreased at higher negative pressure loading. With the amplitude of the mallear tip, the same tendency was observed. The resonance frequency shifted to a higher frequency range with pressure loading. 5) Under positive pressure, the vibration pattern remained unchanged below 2 kHz, and above 3 kH, sectional vibrations changed to the simple vibrations.(ABSTRACT TRUNCATED AT 250 WORDS)

Animals↗

In vivo labeling of the dopamine D2 receptor with N-11C-methyl-benperidol.

A new dopamine D2 receptor radiotracer, N-11C-methyl-benperidol (11C-NMB), was prepared and its in vivo biologic behavior in mice and a baboon was studied. Carbon-11-NMB was determined to bind to specific sites characterized as dopamine D2 receptors. The binding was saturable, reversible, and stereospecific. Kinetic studies in the dopamine D2 receptor-rich striatum showed that 11C-NMB was retained five times longer than in receptor-devoid regions, resulting in a high maximum striatal-to-cerebellar ratio of 11:1 at 60 min after injection. From frontal cortex and cortex, on the other hand, the tracer washed out as rapidly as it did from cerebellum, resulting in tissue-to-cerebellar ratios close to one in these regions at any time after injection. Blocking studies confirmed the specificity and selectivity of the 11C-NMB binding to the dopamine D2 receptor. A PET study with 11C-NMB of the baboon brain revealed highly selective labeling of dopamine D2 receptor sites which was blocked by preinjection of raclopride.

Animals↗

Abnormal 13C-fatty acid breath tests in patients treated with valproic acid.

Breath tests using fatty acids labeled with a stable isotope (carbon 13) were carried out on epileptic patients treated with valproic acid in order to detect abnormal fatty acid metabolism. The patients were given 13C-octanoic acid or 13C-palmitic acid orally, and expired air was collected at appropriate intervals for the analysis of 13CO2 content by a mass spectrometer. Eight patients were tested in the palmitic acid breath test and nine patients in the octanoic acid breath test. Controls for these tests were patients treated with antiepileptic drugs other than valproic acid and unmedicated cerebral palsy patients. In the valproic acid-treated group, 13C recovery was reduced by 56% in seven hours on the 13C-palmitic acid breath test, while the octanoic acid breath test showed a 52% reduction in one hour. This suppression of fatty acid oxidation was significantly correlated with dose of valproic acid in both tests. No influence of other drugs was detected, and the effect of administered carnitine was not conclusive. This study demonstrates the usefulness of 13C-labeled fatty acid breath tests in clinical practice.

Adolescent↗

[13C]methacetin breath test for evaluation of liver damage.

Methacetin undergoes rapid O-dealkylation by hepatic microsomal enzyme systems, and the resultant CO2 is present in the expired air. The rate of O-dealkylation of methacetin was assessed by the [13C]methacetin breath test in seven healthy volunteers and 30 patients with histologically proven chronic liver diseases. The 30-min recovery of orally administered [13C]methacetin as 13CO2 in the exhaled air was significantly reduced in patients with chronic aggressive hepatitis and in those with liver cirrhosis but not in patients with chronic persistent hepatitis or healthy controls. Patients with either advanced cirrhosis or hepatocellular carcinoma showed significantly lower values than those with well-compensated cirrhosis. The levels in two patients with late primary biliary cirrhosis were reduced. These results show that the severity of liver damage can be effectively evaluated by [13C]methacetin breath test. In addition, this test is simple, safe, and time efficient.

Acetamides↗

Automated 13CO2 analyzing system for the 13C breath test.

An automated 13CO2 analyzing system for the 13C breath test was designed, built and evaluated. The system, which was designed to be controlled by a micro-computer, includes CO2 purification, 13CO2 abundance measurement, data processing and data filing. This article gives the description of the whole system with flow charts. This system has proved to work well and it has become feasible to dispose of 5 to 6 CO2 samples per hour. With such a system, the 13C breath test will be carried out much more easily and will obtain much greater popularity.

Autoanalysis↗

Somatostatin-like immunoreactivity in rat thyroid. Age-associated S-cell hyperplasia.

Somatostatin-like immunoreactive cells of the rat thyroid gland at various ages were investigated immunohistochemically. The number of cells per lobe in 5 micron sections increased with age. Immunopositive cells were evident as small clusters in the older age group (8 to 24 months old) but not clustered in the younger age group (3 to 5 months old). This type of proliferation was termed S-cell hyperplasia in a manner similar to C-cell hyperplasia observed in the aged rat thyroid.

Aging↗

Primary C cell hyperplasia of the thyroid in Fischer 344 rats. An immunohistochemical study.

C cell proliferation of the thyroid, which was designated as primary C cell hyperplasia (PCCH), was demonstrated in aged Fischer 344 rats in high incidence using the immunohistochemical method for calcitonin. It developed from mild to severe PCCH and resulted in nodular PCCH and tumor formation. The combined incidence of PCCH and nodular PCCH was increased with age and appeared in 60.7% of 7-15 month old group and 92.7% of 16-24 month old group possibly as a preneoplastic C cell lesion. It is almost an equivalent C cell lesion reported in the human thyroid with familial C cell carcinoma and therefore this Fischer 344 rat can provide a useful animal model to study familial C cell tumor of the thyroid.

Animals↗

[Sensitivity and precision of the 13C-breath test].

Sensitivity and precision of the 13C-breath test were assessed by examining a couple of limiting factors caused by the sensitivity of the instrument used for 13CO2 analysis, endogenous fluctuation of 13CO2 abundance, and the residual CO2 in sample storing tubes, vacutainers, etc. For 13CO2 analysis, a mass spectrometer equipped with a dual inlet, a dual collector, and an automated pressure matching system, was used. 15 ml vacutainers were used for sample storage. Endogenous fluctuation of 13CO2 abundance, however, was measured by putting the breath samples directly into the evacuated CO2 purification system, instead of using vacutainers. Endogenous fluctuation (S.D. = 0.202%) was the most significant limiting factor, compared with instrumental limitation (0.085%), or with influence of the residual CO2 (0.136%). Consequently, the sensitivity of the 13C-breath test was figured out to be 0.52%. This sensitivity is about 1,000 times lower than that of 14C-breath test. The precision was linearly dependent on 13C increase from basal 13C observed after administration of 13C enriched compounds, delta 13C, and was determined to be expressed as 1.94 delta 13C.

Adult↗